• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of food on the serum concentration profile of enteric-coated valproic acid.

作者信息

Fischer J H, Barr A N, Paloucek F P, Dorociak J V, Spunt A L

机构信息

Clinical Pharmacokinetics Laboratory, College of Pharmacy, University of Illinois, Chicago 60612.

出版信息

Neurology. 1988 Aug;38(8):1319-22. doi: 10.1212/wnl.38.8.1319.

DOI:10.1212/wnl.38.8.1319
PMID:3135514
Abstract

We evaluated the effect of food on the serum concentration profile of enteric-coated divalproex sodium (EC-VPA) in six adult volunteers following a single dose and in six patients during chronic-dose administration. The results demonstrated a significant delay but no decrease in extent of EC-VPA absorption following administration with food. To monitor serum concentrations in patients receiving EC-VPA, consideration of sampling time in relation both to time of dose and meals is required.

摘要

相似文献

1
Effect of food on the serum concentration profile of enteric-coated valproic acid.
Neurology. 1988 Aug;38(8):1319-22. doi: 10.1212/wnl.38.8.1319.
2
Meal-dependent absorption of enteric-coated sodium valproate.
Epilepsia. 1980 Jun;21(3):273-80. doi: 10.1111/j.1528-1157.1980.tb04073.x.
3
Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.丙戊酸钠缓释片与长效释放片的比较吸收曲线——临床意义
Ann Pharmacother. 2006 Apr;40(4):619-25. doi: 10.1345/aph.1G617. Epub 2006 Mar 28.
4
Comparative steady state serum levels of valproic acid administered as two different formulations--Deprakine and Orfiril.
Acta Neurol Scand. 1979 Dec;60(6):371-4. doi: 10.1111/j.1600-0404.1979.tb07663.x.
5
Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.肠溶型丙戊酸二钠延迟和/或漏服剂量对丙戊酸浓度的影响:模拟分析及给临床医生的剂量替代建议
J Clin Pharm Ther. 2006 Aug;31(4):321-9. doi: 10.1111/j.1365-2710.2006.00739.x.
6
Comparison of the effectiveness of several formulations of sodium valproate: tablets, enteric-coated capsules, solutions and rectal capsules.
Ital J Neurol Sci. 1982 Oct;3(3):197-200. doi: 10.1007/BF02043309.
7
Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy.每日一次给药适用于广泛剂量范围内的缓释双丙戊酸钠,但不适用于肠包衣、延迟释放的双丙戊酸钠:通过计算机模拟得出的证据及其对癫痫治疗的影响。
Epilepsy Res. 2009 Dec;87(2-3):260-7. doi: 10.1016/j.eplepsyres.2009.09.015. Epub 2009 Nov 4.
8
Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States.美国市售丙戊酸/双丙戊酸钠口服制剂的独特吸收特性。
Epilepsy Res. 2007 Mar;73(3):275-83. doi: 10.1016/j.eplepsyres.2006.11.005. Epub 2007 Jan 8.
9
Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations.癫痫患者每12小时服用缓释丙戊酸/divalproex:对血浆丙戊酸浓度的影响。
Epilepsy Behav. 2006 Mar;8(2):391-6. doi: 10.1016/j.yebeh.2005.12.004.
10
Single-dose kinetics and bioavailability of sodium-hydrogen divalproate.
Clin Neuropharmacol. 1985;8(2):156-64. doi: 10.1097/00002826-198506000-00005.

引用本文的文献

1
Enteral administration of protein supplement and valproate: A potential pharmacokinetic interaction.蛋白质补充剂与丙戊酸盐的肠内给药:一种潜在的药代动力学相互作用。
Ment Health Clin. 2018 Mar 23;7(1):10-12. doi: 10.9740/mhc.2017.01.010. eCollection 2017 Jan.
2
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.预防性治疗偏头痛药物的药代动力学变异性。
CNS Drugs. 2017 May;31(5):389-403. doi: 10.1007/s40263-017-0430-3.
3
Divalproex to divalproex extended release conversion.丙戊酸钠到丙戊酸钠缓释剂型的转换。
Clin Drug Investig. 2004;24(9):495-508. doi: 10.2165/00044011-200424090-00001.